Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Breast Cancer Research

Fig. 4

From: Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30

Fig. 4

Breast cancer-specific and overall survival curves according to chemotherapy use among patients with age ≤ 70 years and the RS 26–30, stratified by age and tumor grade. a Breast cancer-specific survival in patients ≤ 56 years of age, b overall survival in patients ≤ 56 years of age, c breast cancer-specific survival in patients 57–70 years of age, d overall survival in patients 57–70 years of age, e breast cancer-specific survival in patients with grade I–II tumor, f overall survival in patients with grade I–II tumor, g breast cancer-specific survival in patients with grade III tumor, and h overall survival in patients with grade III tumor

Back to article page